Skip to main content
Funded Studies

Martin E. Sanders, MD

Chairman and Chief Executive Officer at Io Therapeutics, Inc.

Location: Santa Ana, CA United States

Martin E. Sanders, MD, received his medical degree from the University of Chicago; served as an intern and resident in Internal Medicine at Washington University Medical Center in St. Louis; and completed three post-doctoral fellowships: in Allergy/Clinical Immunology at the NIAID/NIH, in rheumatology at Johns Hopkins Medical School, and in cancer immunology at the Immunology Branch of the NCI/NIH. He is board certified in internal medicine, allergy/clinical immunology, and rheumatology.

Dr. Sanders' career has spanned 30+ years including basic research, drug discovery research, product development research, patient care, senior officer positions at multiple companies, venture capital partnership, and membership on multiple for-profit and non-profit boards. He is a co-founder of Io Therapeutics, and currently serves as its board chairman and chief executive officer.


Associated Grants

  • Evaluation of the RXR Agonist Compound IRX4204


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.